Evidence map›Paper›PMID 37931686›Full record

Trial reportJournal of substance use and addiction treatment2024

Anxiety sensitivity reduction-smoking cessation intervention among individuals who engage in dual cigarette and cannabis use: A secondary analysis.

Michael J Zvolensky, Jafar Bakhshaie, Brooke Y Redmond, Lorra Garey, Marcel de Dios, Miguel Ángel Cano, Norman B Schmidt

Open access · greenAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Journal of substance use and addiction treatment, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Michael J ZvolenskyDepartment of Psychology, University of Houston, Houston, TX, USA; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; HEALTH Institute, University of Houston, Houston, TX, USA. Electronic address: mjzvolen@central.uh.edu.
Jafar BakhshaieIntegrated Brain Health Clinical and Research Program, Massachusetts General Hospital, 1 Bowdoin Square, Suite 100, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
Brooke Y RedmondDepartment of Psychology, University of Houston, Houston, TX, USA.
Lorra GareyDepartment of Psychology, University of Houston, Houston, TX, USA.
Marcel de DiosDepartment of Psychological, Health, and Learning Sciences, University of Houston, Houston, TX, USA.
Miguel Ángel CanoPeter O'Donnell Jr. School of Public Health, The University of Texas Southwestern Medical Center.
Norman B SchmidtDepartment of Psychology, Florida State University, Tallahassee, FL, USA.
University of Houston · USFlorida State University · USMassachusetts General Hospital · USThe University of Texas Southwestern Medical Center · US

Funding

Testing a Digital Therapeutic for Smoking Cessation among Hispanic Persons who SmokeU54MD015946 · NIMHD · UNIVERSITY OF HOUSTON · PI Bettina M. Beech · 2020 to 2026
$22.0M
Latinx Hazardous Drinkers: Evaluating MicroaggressionsK23AA030804 · NIAAA · UNIVERSITY OF HOUSTON · PI Brooke Y Redmond · 2023 to 2026
$756k
Evaluating Microaggressions among Latinx Individuals with ObesityR21DK137191 · NIDDK · UNIVERSITY OF HOUSTON · PI REDMOND, BROOKE Y · 2023 to 2023
$611k
NIAAA NIH HHS K23 AA030804NIAAA NIH HHS L60 AA030414NIDDK NIH HHS R21 DK137191NIMHD NIH HHS U54 MD015946
6 · The paper itself

Abstract

introductionCannabis use among individuals who smoke is prevalent in the general population and related to adverse health effects, including higher levels of interoceptive perturbation (i.e., a disturbance in internal experiences). An important aspect of smoking cessation among individuals who co-use cannabis is to address behavioral associations between physiological sensations and habitual behaviors via integrated treatments focused on reducing reactivity to internal perturbations such as anxiety sensitivity (i.e., the belief that such symptoms produce personal harm).

methodsThe current study involved a secondary analysis of a randomized clinical trial (RCT) of an integrated anxiety sensitivity-smoking cessation intervention compared to standard smoking cessation. The current study sought to extend findings from the initial trial to examine if the integrated intervention produced better smoking cessation outcomes than standard care among individuals who engage in dual cigarette and cannabis use. Participants were 149 adults who engage in dual cigarette and cannabis use (41.6 % female; M

resultsResults indicated that the anxiety sensitivity intervention produced statistically significant differences in distal (long-term) smoking abstinence at 3-, 6-, and 12-month follow-up assessments but not proximal (short-term; quit-week to 2-weeks) smoking abstinence.

conclusionsOverall, the potential of an integrated anxiety sensitivity smoking cessation intervention to yield better long-term smoking abstinence rates than standard cessation treatment among individuals who engage in dual cigarette and cannabis use is clinically significant.

Indexed as

CannabisHallucinogensSmoking CessationTobacco ProductsAdultAnxietyBehavior TherapyFemaleHumansMaleHallucinogensAnxiety sensitivityCannabisDual useSmoking cessation

Identifiers

PMID37931686
PMCPMC11200176
OpenAlexW4388366324

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.